Financhill
Sell
49

HQY Quote, Financials, Valuation and Earnings

Last price:
$79.48
Seasonality move :
7.68%
Day range:
$77.98 - $80.17
52-week range:
$74.07 - $116.65
Dividend yield:
0%
P/E ratio:
36.41x
P/S ratio:
5.42x
P/B ratio:
3.18x
Volume:
1.2M
Avg. volume:
1M
1-year change:
-29.11%
Market cap:
$6.8B
Revenue:
$1.2B
EPS (TTM):
$2.18

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
HQY
HealthEquity, Inc.
$350.9M $1.14 6.07% 86.18% $119.13
DTRK
DATATRAK International, Inc.
-- -- -- -- --
HSTM
HealthStream, Inc.
$78.1M $0.24 4.78% 9.65% $32.50
SCNX
Scienture Holdings, Inc.
-- -- -- -- --
SLP
Simulations Plus, Inc.
$21.1M $0.32 -3.45% 101.19% $24.67
VNTH
Nano Mobile Healthcare
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
HQY
HealthEquity, Inc.
$79.45 $119.13 $6.8B 36.41x $0.00 0% 5.42x
DTRK
DATATRAK International, Inc.
$0.3738 -- $1M -- $0.00 0% 0.16x
HSTM
HealthStream, Inc.
$20.09 $32.50 $596M 29.44x $0.03 0.62% 2.04x
SCNX
Scienture Holdings, Inc.
$0.48 -- $19.4M -- $1.50 0% 9.37x
SLP
Simulations Plus, Inc.
$14.57 $24.67 $293.5M 49.91x $0.06 0% 3.74x
VNTH
Nano Mobile Healthcare
$0.0002 -- $160.7K -- $0.00 0% --
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
HQY
HealthEquity, Inc.
32.52% 2.297 12.7% 3.49x
DTRK
DATATRAK International, Inc.
-- 9.065 -- --
HSTM
HealthStream, Inc.
4.2% -0.713 1.83% 1.12x
SCNX
Scienture Holdings, Inc.
3% 5.147 13% 0.13x
SLP
Simulations Plus, Inc.
0.44% -1.250 0.16% 5.24x
VNTH
Nano Mobile Healthcare
-- -0.927 -- --
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
HQY
HealthEquity, Inc.
$201.1M $79.9M 5.97% 9.01% 24.79% $127.2M
DTRK
DATATRAK International, Inc.
-- -- -- -- -- --
HSTM
HealthStream, Inc.
$39.1M $7.6M 5.55% 5.82% 9.9% $10.5M
SCNX
Scienture Holdings, Inc.
$567.7K -$4.4M -23.89% -24.88% -739.19% -$3.2M
SLP
Simulations Plus, Inc.
$10.5M $713K -42.61% -42.84% 3.87% $3.3M
VNTH
Nano Mobile Healthcare
-- -- -- -- -- --

HealthEquity, Inc. vs. Competitors

  • Which has Higher Returns HQY or DTRK?

    DATATRAK International, Inc. has a net margin of 16.05% compared to HealthEquity, Inc.'s net margin of --. HealthEquity, Inc.'s return on equity of 9.01% beat DATATRAK International, Inc.'s return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    HQY
    HealthEquity, Inc.
    62.41% $0.59 $3.2B
    DTRK
    DATATRAK International, Inc.
    -- -- --
  • What do Analysts Say About HQY or DTRK?

    HealthEquity, Inc. has a consensus price target of $119.13, signalling upside risk potential of 49.94%. On the other hand DATATRAK International, Inc. has an analysts' consensus of -- which suggests that it could grow by 6321.41%. Given that DATATRAK International, Inc. has higher upside potential than HealthEquity, Inc., analysts believe DATATRAK International, Inc. is more attractive than HealthEquity, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    HQY
    HealthEquity, Inc.
    9 1 1
    DTRK
    DATATRAK International, Inc.
    0 0 0
  • Is HQY or DTRK More Risky?

    HealthEquity, Inc. has a beta of 0.239, which suggesting that the stock is 76.091% less volatile than S&P 500. In comparison DATATRAK International, Inc. has a beta of 5.272, suggesting its more volatile than the S&P 500 by 427.166%.

  • Which is a Better Dividend Stock HQY or DTRK?

    HealthEquity, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DATATRAK International, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. HealthEquity, Inc. pays -- of its earnings as a dividend. DATATRAK International, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios HQY or DTRK?

    HealthEquity, Inc. quarterly revenues are $322.2M, which are larger than DATATRAK International, Inc. quarterly revenues of --. HealthEquity, Inc.'s net income of $51.7M is higher than DATATRAK International, Inc.'s net income of --. Notably, HealthEquity, Inc.'s price-to-earnings ratio is 36.41x while DATATRAK International, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HealthEquity, Inc. is 5.42x versus 0.16x for DATATRAK International, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HQY
    HealthEquity, Inc.
    5.42x 36.41x $322.2M $51.7M
    DTRK
    DATATRAK International, Inc.
    0.16x -- -- --
  • Which has Higher Returns HQY or HSTM?

    HealthStream, Inc. has a net margin of 16.05% compared to HealthEquity, Inc.'s net margin of 7.96%. HealthEquity, Inc.'s return on equity of 9.01% beat HealthStream, Inc.'s return on equity of 5.82%.

    Company Gross Margin Earnings Per Share Invested Capital
    HQY
    HealthEquity, Inc.
    62.41% $0.59 $3.2B
    HSTM
    HealthStream, Inc.
    51.19% $0.20 $364.5M
  • What do Analysts Say About HQY or HSTM?

    HealthEquity, Inc. has a consensus price target of $119.13, signalling upside risk potential of 49.94%. On the other hand HealthStream, Inc. has an analysts' consensus of $32.50 which suggests that it could grow by 61.77%. Given that HealthStream, Inc. has higher upside potential than HealthEquity, Inc., analysts believe HealthStream, Inc. is more attractive than HealthEquity, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    HQY
    HealthEquity, Inc.
    9 1 1
    HSTM
    HealthStream, Inc.
    2 3 0
  • Is HQY or HSTM More Risky?

    HealthEquity, Inc. has a beta of 0.239, which suggesting that the stock is 76.091% less volatile than S&P 500. In comparison HealthStream, Inc. has a beta of 0.439, suggesting its less volatile than the S&P 500 by 56.064%.

  • Which is a Better Dividend Stock HQY or HSTM?

    HealthEquity, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. HealthStream, Inc. offers a yield of 0.62% to investors and pays a quarterly dividend of $0.03 per share. HealthEquity, Inc. pays -- of its earnings as a dividend. HealthStream, Inc. pays out 17.1% of its earnings as a dividend. HealthStream, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios HQY or HSTM?

    HealthEquity, Inc. quarterly revenues are $322.2M, which are larger than HealthStream, Inc. quarterly revenues of $76.5M. HealthEquity, Inc.'s net income of $51.7M is higher than HealthStream, Inc.'s net income of $6.1M. Notably, HealthEquity, Inc.'s price-to-earnings ratio is 36.41x while HealthStream, Inc.'s PE ratio is 29.44x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HealthEquity, Inc. is 5.42x versus 2.04x for HealthStream, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HQY
    HealthEquity, Inc.
    5.42x 36.41x $322.2M $51.7M
    HSTM
    HealthStream, Inc.
    2.04x 29.44x $76.5M $6.1M
  • Which has Higher Returns HQY or SCNX?

    Scienture Holdings, Inc. has a net margin of 16.05% compared to HealthEquity, Inc.'s net margin of -611.42%. HealthEquity, Inc.'s return on equity of 9.01% beat Scienture Holdings, Inc.'s return on equity of -24.88%.

    Company Gross Margin Earnings Per Share Invested Capital
    HQY
    HealthEquity, Inc.
    62.41% $0.59 $3.2B
    SCNX
    Scienture Holdings, Inc.
    96.22% -$0.19 $85.2M
  • What do Analysts Say About HQY or SCNX?

    HealthEquity, Inc. has a consensus price target of $119.13, signalling upside risk potential of 49.94%. On the other hand Scienture Holdings, Inc. has an analysts' consensus of -- which suggests that it could grow by 1313.32%. Given that Scienture Holdings, Inc. has higher upside potential than HealthEquity, Inc., analysts believe Scienture Holdings, Inc. is more attractive than HealthEquity, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    HQY
    HealthEquity, Inc.
    9 1 1
    SCNX
    Scienture Holdings, Inc.
    0 0 0
  • Is HQY or SCNX More Risky?

    HealthEquity, Inc. has a beta of 0.239, which suggesting that the stock is 76.091% less volatile than S&P 500. In comparison Scienture Holdings, Inc. has a beta of 3.033, suggesting its more volatile than the S&P 500 by 203.315%.

  • Which is a Better Dividend Stock HQY or SCNX?

    HealthEquity, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Scienture Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $1.50 per share. HealthEquity, Inc. pays -- of its earnings as a dividend. Scienture Holdings, Inc. pays out 81.44% of its earnings as a dividend. Scienture Holdings, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios HQY or SCNX?

    HealthEquity, Inc. quarterly revenues are $322.2M, which are larger than Scienture Holdings, Inc. quarterly revenues of $590K. HealthEquity, Inc.'s net income of $51.7M is higher than Scienture Holdings, Inc.'s net income of -$3.6M. Notably, HealthEquity, Inc.'s price-to-earnings ratio is 36.41x while Scienture Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HealthEquity, Inc. is 5.42x versus 9.37x for Scienture Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HQY
    HealthEquity, Inc.
    5.42x 36.41x $322.2M $51.7M
    SCNX
    Scienture Holdings, Inc.
    9.37x -- $590K -$3.6M
  • Which has Higher Returns HQY or SLP?

    Simulations Plus, Inc. has a net margin of 16.05% compared to HealthEquity, Inc.'s net margin of 3.67%. HealthEquity, Inc.'s return on equity of 9.01% beat Simulations Plus, Inc.'s return on equity of -42.84%.

    Company Gross Margin Earnings Per Share Invested Capital
    HQY
    HealthEquity, Inc.
    62.41% $0.59 $3.2B
    SLP
    Simulations Plus, Inc.
    56.95% $0.03 $127.7M
  • What do Analysts Say About HQY or SLP?

    HealthEquity, Inc. has a consensus price target of $119.13, signalling upside risk potential of 49.94%. On the other hand Simulations Plus, Inc. has an analysts' consensus of $24.67 which suggests that it could grow by 69.3%. Given that Simulations Plus, Inc. has higher upside potential than HealthEquity, Inc., analysts believe Simulations Plus, Inc. is more attractive than HealthEquity, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    HQY
    HealthEquity, Inc.
    9 1 1
    SLP
    Simulations Plus, Inc.
    3 4 0
  • Is HQY or SLP More Risky?

    HealthEquity, Inc. has a beta of 0.239, which suggesting that the stock is 76.091% less volatile than S&P 500. In comparison Simulations Plus, Inc. has a beta of 1.120, suggesting its more volatile than the S&P 500 by 11.977%.

  • Which is a Better Dividend Stock HQY or SLP?

    HealthEquity, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Simulations Plus, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.06 per share. HealthEquity, Inc. pays -- of its earnings as a dividend. Simulations Plus, Inc. pays out -48.18% of its earnings as a dividend.

  • Which has Better Financial Ratios HQY or SLP?

    HealthEquity, Inc. quarterly revenues are $322.2M, which are larger than Simulations Plus, Inc. quarterly revenues of $18.4M. HealthEquity, Inc.'s net income of $51.7M is higher than Simulations Plus, Inc.'s net income of $676K. Notably, HealthEquity, Inc.'s price-to-earnings ratio is 36.41x while Simulations Plus, Inc.'s PE ratio is 49.91x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HealthEquity, Inc. is 5.42x versus 3.74x for Simulations Plus, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HQY
    HealthEquity, Inc.
    5.42x 36.41x $322.2M $51.7M
    SLP
    Simulations Plus, Inc.
    3.74x 49.91x $18.4M $676K
  • Which has Higher Returns HQY or VNTH?

    Nano Mobile Healthcare has a net margin of 16.05% compared to HealthEquity, Inc.'s net margin of --. HealthEquity, Inc.'s return on equity of 9.01% beat Nano Mobile Healthcare's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    HQY
    HealthEquity, Inc.
    62.41% $0.59 $3.2B
    VNTH
    Nano Mobile Healthcare
    -- -- --
  • What do Analysts Say About HQY or VNTH?

    HealthEquity, Inc. has a consensus price target of $119.13, signalling upside risk potential of 49.94%. On the other hand Nano Mobile Healthcare has an analysts' consensus of -- which suggests that it could fall by --. Given that HealthEquity, Inc. has higher upside potential than Nano Mobile Healthcare, analysts believe HealthEquity, Inc. is more attractive than Nano Mobile Healthcare.

    Company Buy Ratings Hold Ratings Sell Ratings
    HQY
    HealthEquity, Inc.
    9 1 1
    VNTH
    Nano Mobile Healthcare
    0 0 0
  • Is HQY or VNTH More Risky?

    HealthEquity, Inc. has a beta of 0.239, which suggesting that the stock is 76.091% less volatile than S&P 500. In comparison Nano Mobile Healthcare has a beta of -1.161, suggesting its less volatile than the S&P 500 by 216.13%.

  • Which is a Better Dividend Stock HQY or VNTH?

    HealthEquity, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nano Mobile Healthcare offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. HealthEquity, Inc. pays -- of its earnings as a dividend. Nano Mobile Healthcare pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios HQY or VNTH?

    HealthEquity, Inc. quarterly revenues are $322.2M, which are larger than Nano Mobile Healthcare quarterly revenues of --. HealthEquity, Inc.'s net income of $51.7M is higher than Nano Mobile Healthcare's net income of --. Notably, HealthEquity, Inc.'s price-to-earnings ratio is 36.41x while Nano Mobile Healthcare's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HealthEquity, Inc. is 5.42x versus -- for Nano Mobile Healthcare. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HQY
    HealthEquity, Inc.
    5.42x 36.41x $322.2M $51.7M
    VNTH
    Nano Mobile Healthcare
    -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will UnitedHealth Stock Recover?
Will UnitedHealth Stock Recover?

Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…

Is Lumentum The Best Laser Stock to Buy?
Is Lumentum The Best Laser Stock to Buy?

Though certainly less well-known than the huge tech businesses that…

Is Planet Fitness Stock Undervalued?
Is Planet Fitness Stock Undervalued?

Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…

Stock Ideas

Buy
56
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
53
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 30x

Alerts

Sell
40
BILL alert for Feb 7

Bill Holdings, Inc. [BILL] is up 37.11% over the past day.

Buy
75
PRLB alert for Feb 7

Proto Labs, Inc. [PRLB] is up 28.33% over the past day.

Sell
30
MSTR alert for Feb 7

Strategy, Inc. [MSTR] is up 26.08% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock